Insider Holders & Insider Ownership - Fresh Tracks Therapeutics Inc. (FRTX)

List of insiders holdings for Fresh Tracks Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
SINGER JAMES R
10% Owner
2016-01-27 15:42:544,540,000
0
4,540,000Form 13G
V-Sciences Investments Pte Ltd
Temasek Life Sciences Private LTD
Fullerton Management Pte Ltd
TEMASEK HOLDINGS (PRIVATE) LTD
10% Owner
2009-06-12 16:29:522,920,224
0
2,920,224Form 13G
MARXE AUSTIN W & GREENHOUSE DAVID M
10% Owner
2011-04-11 13:18:012,661,779
0
2,661,779Form 13G
AnGes MG Inc.
10% Owner
2016-08-10 16:01:252,058,528
0
2,058,528Form 3
CAMPBELL ROBERT H
Director
2012-11-28 16:12:301,631,676
26,000
1,657,676Form 4
Exploration Capital LLC
10% Owner
2024-05-23 17:29:141,370,478
0
1,370,478Form 4
ARMISTICE CAPITAL LLC
Armistice Capital Master Fund Ltd.
Boyd Steven
10% Owner
2020-06-26 16:39:581,331,248
0
1,331,248Form 13G
Exploration Capital Fund LP
Exploration Capital LLC
Exploration Capital General Partner LLC
10% Owner
2024-05-08 16:01:471,273,024
0
1,273,024Form 13D
Brown Robert Busard
Chief Executive Officer
2022-05-09 16:05:541,100,000
0
1,100,000Form 4
Luchi Monica E.
Chief Medical Officer
2022-05-09 16:16:12325,000
0
325,000Form 4
ABERCROMBIE GEORGE B
CHIEF EXECUTIVE OFFICER
2020-02-19 17:07:0984,477
131,194
215,671Form 4
BILINSKY IGOR
Sr VP, Corporate Development
2015-07-15 16:49:35193,798
0
193,798Form 4
Breton Jose
Chief Accounting Officer
2022-05-09 16:17:30150,000
0
150,000Form 4
Broadfoot Jill Marie
Sr Vice President, CFO, Sec
2013-04-03 18:29:33145,649
0
145,649Form 4
Levy Adam Scott
Chief Business Officer
2020-03-18 16:30:15131,364
0
131,364Form 4
ROLLAND ALAIN P PHD
Exec VP, Product Development
2013-08-23 19:15:47127,583
0
127,583Form 4
Ahuja Sanjeev
Chief Medical Officer
2019-11-05 12:05:5583,313
0
83,313Form 4
Ju William
Director
2019-09-09 20:40:2460,411
13,363
73,774Form 3
SHERWIN STEPHEN A
Director
2015-05-26 13:25:1672,003
0
72,003Form 4
Mammen Mammen
Sr VP, Clinical Development
2018-01-10 11:29:3570,000
0
70,000Form 4
Ramos Anthony Alan
VP, Chief Financial Officer
2018-01-10 11:25:4570,000
0
70,000Form 4
VERU DENNISON T
Director
2022-05-17 17:14:1365,000
0
65,000Form 4
LYONS GARY A
Director
2022-05-17 17:15:0565,000
0
65,000Form 4
SAMANT VIJAY B
Director
2022-05-17 17:16:3265,000
0
65,000Form 4
HARDY REGINALD L
CHAIRMAN OF THE BOARD
2022-05-17 17:18:2165,000
0
65,000Form 4
SMITH LAWRENCE RUSSELL
Sr VP, Research
2018-01-10 11:05:5760,000
0
60,000Form 4
Carruthers R Michael
Chief Financial Officer
2020-03-18 16:30:2755,808
0
55,808Form 4
KASLOW DAVID C MD
Chief Scientific Officer
2006-02-23 17:24:1943,405
0
43,405Form 4
Sklawer Andrew D
President and CEO
2023-10-04 21:41:2539,269
0
39,269Form 4
Chadha Deepak
Former Chief R&D Officer & COO
2023-12-11 16:09:5122,314
0
22,314Form 4
McAvoy David R.
Gen Counsel, CCO, & Secretary
2023-10-04 21:40:2416,061
310
16,371Form 4
INGLE M BLAKE
Director
2005-05-19 16:40:2412,500
0
12,500Form 4
LATTERELL PATRICK F
Director
2003-05-22 17:03:3712,500
0
12,500Form 4
DEMSKI MARTHA J
Vice President & CFO
2004-05-24 14:28:318000
0
8000Form 4
DOUGLAS R GORDON
Director
2018-05-24 11:28:538000
0
8000Form 4
MERTON ROBERT C
Director
2018-05-24 11:40:016500
0
6500Form 4
Beleson Richard M
Director
2018-05-24 11:36:116500
0
6500Form 4
MORROW GEORGE J
Director
2018-05-24 11:33:046500
0
6500Form 4
SHENK THOMAS E
Director
2018-05-24 11:26:486500
0
6500Form 4
Marchio Albert N II
CEO and CFO
2024-01-09 16:10:040
0
0Form 4
Fox-Collis Aaron
VP of Finance & CAO
2024-01-09 16:11:030
0
0Form 4